To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of LYNC-101 for Injection in Healthy Adult Participants
Clinical trial NCT07505030 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07505030
- Sponsor
- LyncBio Therapeutics Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-25
- Primary completion
- 2027-03-19
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.